Misler S, Gee W M, Gillis K D, Scharp D W, Falke L C
Department of Internal Medicine, Jewish Hospital, Washington University, St Louis, Missouri.
Diabetes. 1989 Apr;38(4):422-7. doi: 10.2337/diab.38.4.422.
In patch-clamped surface cells of human islets, we identified an inwardly rectifying, voltage-independent K+ channel that may be a crucial link between substrate metabolism and depolarization-induced insulin secretion. It is the major channel open at rest. It closes on exposure of the cell to secretagogue concentrations of glucose or other metabolic fuels and oral hypoglycemic sulfonylureas but reopens on addition of either a metabolic inhibitor that prevents substrate utilization or the hyperglycemic sulfonamide diazoxide. Onset of electrical activity coincides with channel closure by the secretagogues. In excised patches, the activity of this channel is inhibited at its cytoplasmic surface by ATP. These results suggest that in humans, as in rodents, 1) rises in cytoplasmic ATP levels during substrate metabolism trigger K+-channel closure and cell depolarization and 2) clinically useful sulfonamides modulate glucose-induced insulin secretion, in part by affecting a readily identifiable resting conductance pathway for K+.
在人胰岛的膜片钳表面细胞中,我们鉴定出一种内向整流、电压不依赖的钾通道,它可能是底物代谢与去极化诱导的胰岛素分泌之间的关键联系。它是静息时开放的主要通道。当细胞暴露于促分泌剂浓度的葡萄糖或其他代谢燃料以及口服降糖磺脲类药物时,该通道关闭,但在添加阻止底物利用的代谢抑制剂或高血糖磺酰胺二氮嗪后重新开放。电活动的开始与促分泌剂引起的通道关闭同时发生。在切除的膜片中,该通道的活性在其细胞质表面受到ATP的抑制。这些结果表明,在人类中,与在啮齿动物中一样,1)底物代谢过程中细胞质ATP水平的升高触发钾通道关闭和细胞去极化,2)临床上有用的磺酰胺类药物部分通过影响易于识别的钾离子静息电导途径来调节葡萄糖诱导的胰岛素分泌。